Close Menu

The ASHG meeting is in full swing with sunburned scientists showing up to give their talks and everyone getting adjusted to local time here in Hawaii. (Yep, Daily Scan's on the scene.) This week, attendees got caught up on what the 1,000 Genomes project is up to — the University of Oxford's Gil McVean said to keep an eye out for data from the initiative's pilot studies in November or December.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.

The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.

The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.

In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.